A Buprenorphine Program Evaluation Before and During the COVID-19 Pandemic

This project evaluated the service delivery (ie, attendance rate) of a buprenorphine management treatment program and compared patient recovery-related information between service methods. This was a medical record review and cross-sectional comparison of pre–COVID-19 vs post onset of COVID-19 data....

Descripción completa

Detalles Bibliográficos
Autores principales: Hageman, Thomas M., Palmer, Joshua, Mullick, Prabir, Lee, Heeyoung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Featured Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8730707/
https://www.ncbi.nlm.nih.gov/pubmed/35013677
http://dx.doi.org/10.1016/j.nurpra.2021.12.025
_version_ 1784627193421234176
author Hageman, Thomas M.
Palmer, Joshua
Mullick, Prabir
Lee, Heeyoung
author_facet Hageman, Thomas M.
Palmer, Joshua
Mullick, Prabir
Lee, Heeyoung
author_sort Hageman, Thomas M.
collection PubMed
description This project evaluated the service delivery (ie, attendance rate) of a buprenorphine management treatment program and compared patient recovery-related information between service methods. This was a medical record review and cross-sectional comparison of pre–COVID-19 vs post onset of COVID-19 data. In the sample of 28 adults, mean attendance rates did not differ significantly before (99.46%) vs during the pandemic (96.13%; t = 1.92, P = .07). Patient participation in therapy before and during the pandemic did differ significantly (χ(2) = 1.98, P = .03). The use of telemental health services within a BMT program may be a viable option when normal in-person services are disrupted.
format Online
Article
Text
id pubmed-8730707
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-87307072022-01-06 A Buprenorphine Program Evaluation Before and During the COVID-19 Pandemic Hageman, Thomas M. Palmer, Joshua Mullick, Prabir Lee, Heeyoung J Nurse Pract Featured Article This project evaluated the service delivery (ie, attendance rate) of a buprenorphine management treatment program and compared patient recovery-related information between service methods. This was a medical record review and cross-sectional comparison of pre–COVID-19 vs post onset of COVID-19 data. In the sample of 28 adults, mean attendance rates did not differ significantly before (99.46%) vs during the pandemic (96.13%; t = 1.92, P = .07). Patient participation in therapy before and during the pandemic did differ significantly (χ(2) = 1.98, P = .03). The use of telemental health services within a BMT program may be a viable option when normal in-person services are disrupted. Elsevier 2022-03 2022-01-05 /pmc/articles/PMC8730707/ /pubmed/35013677 http://dx.doi.org/10.1016/j.nurpra.2021.12.025 Text en Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Featured Article
Hageman, Thomas M.
Palmer, Joshua
Mullick, Prabir
Lee, Heeyoung
A Buprenorphine Program Evaluation Before and During the COVID-19 Pandemic
title A Buprenorphine Program Evaluation Before and During the COVID-19 Pandemic
title_full A Buprenorphine Program Evaluation Before and During the COVID-19 Pandemic
title_fullStr A Buprenorphine Program Evaluation Before and During the COVID-19 Pandemic
title_full_unstemmed A Buprenorphine Program Evaluation Before and During the COVID-19 Pandemic
title_short A Buprenorphine Program Evaluation Before and During the COVID-19 Pandemic
title_sort buprenorphine program evaluation before and during the covid-19 pandemic
topic Featured Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8730707/
https://www.ncbi.nlm.nih.gov/pubmed/35013677
http://dx.doi.org/10.1016/j.nurpra.2021.12.025
work_keys_str_mv AT hagemanthomasm abuprenorphineprogramevaluationbeforeandduringthecovid19pandemic
AT palmerjoshua abuprenorphineprogramevaluationbeforeandduringthecovid19pandemic
AT mullickprabir abuprenorphineprogramevaluationbeforeandduringthecovid19pandemic
AT leeheeyoung abuprenorphineprogramevaluationbeforeandduringthecovid19pandemic
AT hagemanthomasm buprenorphineprogramevaluationbeforeandduringthecovid19pandemic
AT palmerjoshua buprenorphineprogramevaluationbeforeandduringthecovid19pandemic
AT mullickprabir buprenorphineprogramevaluationbeforeandduringthecovid19pandemic
AT leeheeyoung buprenorphineprogramevaluationbeforeandduringthecovid19pandemic

Ejemplares similares